Triostat - 42023-120-01 - (liothyronine sodium)

Alphabetical Index


Drug Information of Triostat

Product NDC: 42023-120
Proprietary Name: Triostat
Non Proprietary Name: liothyronine sodium
Active Ingredient(s): 10    ug/mL & nbsp;   liothyronine sodium
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of Triostat

Product NDC: 42023-120
Labeler Name: JHP Pharmaceuticals LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020105
Marketing Category: NDA
Start Marketing Date: 20071001

Package Information of Triostat

Package NDC: 42023-120-01
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (42023-120-01) > 1 mL in 1 VIAL, SINGLE-USE

NDC Information of Triostat

NDC Code 42023-120-01
Proprietary Name Triostat
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (42023-120-01) > 1 mL in 1 VIAL, SINGLE-USE
Product NDC 42023-120
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name liothyronine sodium
Dosage Form Name INJECTION
Route Name INTRAVENOUS
Start Marketing Date 20071001
Marketing Category Name NDA
Labeler Name JHP Pharmaceuticals LLC
Substance Name LIOTHYRONINE SODIUM
Strength Number 10
Strength Unit ug/mL
Pharmaceutical Classes l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient]

Complete Information of Triostat


General Information